PalOctPM: Difference between revisions
From Bioblast
(Created page with "{{MitoPedia |abbr=PalOctPM |description='''PalOctPM''': Palmitoylcarnitine & Octanoylcarnitine & Pyruvate & Malate. '''MitoPathway control state:''' FN '...") |
Beno Marija (talk | contribs) No edit summary |
||
| Line 14: | Line 14: | ||
::::» [[Fatty acid oxidation pathway control state]] | ::::» [[Fatty acid oxidation pathway control state]] | ||
::::» [[FN]] | ::::» [[FN]] | ||
::::» [[NADH | ::::» [[NADH electron transfer-pathway state]] | ||
== PalOctPM<sub>''L''</sub> == | == PalOctPM<sub>''L''</sub> == | ||
Latest revision as of 14:36, 26 August 2020
- high-resolution terminology - matching measurements at high-resolution
PalOctPM
Description
PalOctPM: Palmitoylcarnitine & Octanoylcarnitine & Pyruvate & Malate.
MitoPathway control state: FN
SUIT protocols: SUIT-019
Abbreviation: PalOctPM
Reference: SUIT reference protocol
MitoPedia concepts:
SUIT state
- More details
PalOctPML
PalOctPM in the LEAK state can be evaluated in the following SUIT protocols:
PalOctPMP
PalOctPM in the OXPHOS state can be evaluated in the following SUIT protocols:
PalOctPME
PalOctPM in the ET state can be evaluated in the following SUIT protocols:
